Predicting Antibiotic Tolerance in hvKP and cKP Respiratory Infections Through Biofilm Formation Analysis and Its Resistance Implications

DOI: https://doi.org/10.2147/idr.s449712

2024-04-18

Infection and Drug Resistance

Abstract:Zhongwei Wen, Yiqiang Chen, Tangjuan Liu, Jiahui Han, Yuting Jiang, Ke Zhang Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China Correspondence: Yiqiang Chen, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, People's Republic of China, Email Introduction: Respiratory infections are a major global health concern, with Klebsiella pneumoniae standing out due to its evolving antibiotic resistance. This study compares the resistance profiles of hypervirulent Klebsiella pneumoniae (hvKP) and classical Klebsiella pneumoniae (cKP), aiming to shed light on their clinical implications. Methods: We analyzed 86 cases, comprising 42 hvKP and 44 cKP strains, using comprehensive antimicrobial susceptibility testing and clinical data evaluation to assess antibiotic tolerance and resistance mechanisms. Results: Our findings reveal distinct resistance patterns between hvKP and cKP, highlighting the role of chromosomal mutations and plasmid-mediated gene transfer in conferring antibiotic resistance. Notably, hvKP strains exhibited unique resistance trends, including the production of extended-spectrum β-lactamases (ESBLs) and carbapenemases, differing from those of cKP. Discussion: This research underscores the importance of continuous surveillance and the development of targeted therapies against antibiotic-resistant Klebsiella pneumoniae. It emphasizes the critical need for judicious antibiotic use and novel therapeutic approaches to combat respiratory infections caused by these increasingly resistant pathogens. Keywords: Klebsiella pneumoniae, antibiotic resistance, hypervirulent Klebsiella pneumoniae , hvKP, classical Klebsiella pneumoniae , cKP, public health In the realm of infectious diseases, respiratory infections remain a formidable challenge, accounting for significant morbidity and mortality worldwide. 1 Among the diverse array of pathogens implicated in respiratory tract infections, Klebsiella pneumoniae stands out due to its increasing prevalence and the remarkable ability to develop resistance against multiple antibiotic agents. 2,3 K. pneumoniae can be classified into two major groups: hypervirulent K. pneumoniae (hvKP) and classical K. pneumoniae (cKP), each with distinct pathogenic profiles and clinical implications. 4 Recent years have witnessed a surge in cases involving these two strains, underscoring the urgency to delve deeper into their resistance mechanisms and develop strategies to mitigate their impact on public health. 5,6 hvKP, characterized by its hypermucoviscosity and the ability to cause invasive infections, has been associated with severe clinical manifestations such as liver abscesses, endophthalmitis, and meningitis. 7 On the other hand, cKP is typically linked to hospital-acquired infections, exhibiting a predilection for individuals with compromised immune systems. 8 Despite the differences in their virulence and clinical presentations, both hvKP and cKP pose significant challenges due to their capacity to acquire resistance to commonly used antibiotics. 9 The emergence of antibiotic-resistant strains of K. pneumoniae has been documented globally, with alarming increases in the incidence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) isolates. 10,11 This trend is particularly concerning given the limited therapeutic options available for treating infections caused by these resistant strains. 10 In this context, understanding the antibiotic tolerance profiles of hvKP and cKP becomes paramount, as it holds the key to developing targeted interventions and optimizing antimicrobial therapy. A plethora of studies have shed light on the resistance mechanisms employed by K. pneumoniae , revealing a complex interplay of chromosomal mutations and plasmid-mediated gene transfer. 12 In particular, the production of extended-spectrum β-lactamases (ESBLs) and carbapenemases has been identified as a major driver of antibiotic resistance in these strains. 13 These enzymes confer resistance to a wide range of β-lactam antibiotics, including penicillins, cephalosporins, and carbapenems, severely limiting the treatment options and contributing to the high mortality rates associated with these infections. 14,15 In this study, we endeavor to unravel the intricate landscape of antibiotic tolerance in hvKP and cKP respiratory infections, with a particular focus on their resistance profiles and the underlying molecular mechanisms. By leveraging clin -Abstract Truncated-

pharmacology & pharmacy,infectious diseases